J P O'Neill1, J P Hughes, K P Manning, J E Fenton. 1. The Department of Otolaryngology, Head and Neck Surgery, Mid Western Regional Hospital, Dooradoyle, Limerick, Ireland. joneill@rcsi.ie
Abstract
BACKGROUND: Tongue base cancer is one of the most lethal head and neck cancers. There is considerable controversy in the management of this disease with wide variation of opinion within the literature. METHODS: We discuss the presentation, diagnostic and therapeutic strategies which exist in the literature. Articles were reviewed from 1970 to 2007 within the Medline, Pubmed and Cochrane libraries. CONCLUSIONS: Smokers with a history of persistent unilateral neck pain, even in the absence of clinical signs warrant MRI neck imaging. Tongue base cancer organ preservation therapeutic strategies, radiation and concomitant platinum based chemotherapy, currently optimise oncologic and quality of life outcomes.
BACKGROUND: Tongue base cancer is one of the most lethal head and neck cancers. There is considerable controversy in the management of this disease with wide variation of opinion within the literature. METHODS: We discuss the presentation, diagnostic and therapeutic strategies which exist in the literature. Articles were reviewed from 1970 to 2007 within the Medline, Pubmed and Cochrane libraries. CONCLUSIONS: Smokers with a history of persistent unilateral neck pain, even in the absence of clinical signs warrant MRI neck imaging. Tongue base cancer organ preservation therapeutic strategies, radiation and concomitant platinum based chemotherapy, currently optimise oncologic and quality of life outcomes.
Authors: Louis B Harrison; Alfio Ferlito; Ashok R Shaha; Patrick J Bradley; Eric M Genden; Alessandra Rinaldo Journal: Oral Oncol Date: 2003-02 Impact factor: 5.337
Authors: L B Harrison; M J Zelefsky; J G Armstrong; E Carper; J J Gaynor; R B Sessions Journal: Int J Radiat Oncol Biol Phys Date: 1994-11-15 Impact factor: 7.038
Authors: P Balaram; K R Nalinakumari; E Abraham; A Balan; N K Hareendran; H U Bernard; S Y Chan Journal: Int J Cancer Date: 1995-05-16 Impact factor: 7.396